Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$71.68
-3.0%
$55.93
$29.95
$118.84
$3.08B3.03613,786 shs1.25 million shs
Insulet Corporation stock logo
PODD
Insulet
$144.94
+1.6%
$183.55
$140.63
$354.88
$10.04B1.21.68 million shs2.08 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$67.20
-0.9%
$92.92
$60.10
$156.00
$2.32B2.071.92 million shs1.27 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-3.03%+6.68%+44.25%+34.66%+74.45%
Insulet Corporation stock logo
PODD
Insulet
+1.61%-6.41%-9.42%-41.23%-55.20%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.93%-2.51%-31.83%-53.74%-47.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$71.68
-3.0%
$55.93
$29.95
$118.84
$3.08B3.03613,786 shs1.25 million shs
Insulet Corporation stock logo
PODD
Insulet
$144.94
+1.6%
$183.55
$140.63
$354.88
$10.04B1.21.68 million shs2.08 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$67.20
-0.9%
$92.92
$60.10
$156.00
$2.32B2.071.92 million shs1.27 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-3.03%+6.68%+44.25%+34.66%+74.45%
Insulet Corporation stock logo
PODD
Insulet
+1.61%-6.41%-9.42%-41.23%-55.20%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.93%-2.51%-31.83%-53.74%-47.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GRAIL, Inc. stock logo
GRAL
GRAIL
2.38
Hold$67.88-5.31% Downside
Insulet Corporation stock logo
PODD
Insulet
2.74
Moderate Buy$252.0473.90% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.46
Hold$134.0099.40% Upside

Current Analyst Ratings Breakdown

Latest GRAL, TMDX, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetNeutral$175.00 ➝ $165.00
5/27/2026
Insulet Corporation stock logo
PODD
Insulet
Reiterated RatingBuy
5/27/2026
Insulet Corporation stock logo
PODD
Insulet
Reiterated RatingBuy$205.00
5/27/2026
Insulet Corporation stock logo
PODD
Insulet
Reiterated RatingOutperform$280.00
5/26/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetBuy$260.00 ➝ $235.00
5/26/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Reiterated RatingHold
5/26/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetHold$85.00 ➝ $75.00
5/20/2026
Insulet Corporation stock logo
PODD
Insulet
Initiated CoverageOutperform
5/18/2026
Insulet Corporation stock logo
PODD
Insulet
Lower Price TargetBuy$288.00 ➝ $208.00
5/15/2026
Insulet Corporation stock logo
PODD
Insulet
DowngradeHold (C)Hold (C-)
5/12/2026
Insulet Corporation stock logo
PODD
Insulet
Initiated CoverageBuy
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GRAIL, Inc. stock logo
GRAL
GRAIL
$156.12M19.70N/AN/A$58.27 per share1.23
Insulet Corporation stock logo
PODD
Insulet
$2.90B3.46$6.42 per share22.56$18.81 per share7.71
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$635.89M3.65$3.89 per share17.27$14.29 per share4.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GRAIL, Inc. stock logo
GRAL
GRAIL
-$408.35M-$10.37N/AN/AN/A-253.22%-16.42%-14.34%8/11/2026 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$247.10M$4.3033.7118.141.1310.44%26.87%12.01%8/6/2026 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$4.4015.2718.56N/A27.04%22.38%8.46%7/30/2026 (Estimated)

Latest GRAL, TMDX, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
Insulet Corporation stock logo
PODD
Insulet
$1.19$1.42+$0.23$1.30$729.89 million$761.70 million
5/5/2026Q1 2026
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.7629-$2.29+$0.4729-$2.29$39.16 million$40.79 million
5/5/2026Q1 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.62$0.30-$0.32$0.20$174.44 million$173.93 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GRAIL, Inc. stock logo
GRAL
GRAIL
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
11.74
11.74
Insulet Corporation stock logo
PODD
Insulet
0.71
2.49
1.81
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.70
6.74
6.19

Institutional Ownership

CompanyInstitutional Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
Insulet Corporation stock logo
PODD
Insulet
N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
1.83%
Insulet Corporation stock logo
PODD
Insulet
0.36%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GRAIL, Inc. stock logo
GRAL
GRAIL
1,36042.92 million42.13 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.27 million69.02 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.56 million32.18 millionOptionable

Recent News About These Companies

TransMedics Group Signals Growth Amid Margin Squeeze
TransMedics Group (TMDX) Gets a Buy from Needham
TransMedics tumbles after earnings miss

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAIL stock logo

GRAIL NASDAQ:GRAL

$71.68 -2.24 (-3.03%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$72.74 +1.06 (+1.48%)
As of 05/29/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insulet stock logo

Insulet NASDAQ:PODD

$144.94 +2.29 (+1.61%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$145.95 +1.01 (+0.70%)
As of 05/29/2026 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$67.20 -0.63 (-0.93%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$67.31 +0.11 (+0.16%)
As of 05/29/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.